by Jason Heaviland | Feb 19, 2026
MassID is a computational tool that enables near-complete annotation of untargeted metabolomics datasets by assigning identification probabilities to detected features. Traditional workflows often leave many metabolites unannotated, limiting downstream biological...
by Jason Heaviland | Jan 21, 2026 | Uncategorized
The functional foods market has expanded rapidly over the past two decades, driven by consumer interest in products offering health benefits beyond basic nutrition. However, this growth has outpaced the scientific evidence supporting many product claims, creating...
by Jason Heaviland | Jan 12, 2026 | Uncategorized
The Precious Sample Challenge in Clinical Research Clinical and translational research frequently confronts a fundamental constraint: limited biological sample availability. Pediatric studies, rare disease investigations, longitudinal monitoring protocols, and tissue...
by Jason Heaviland | Jan 12, 2026
Payload to Patient: Metabolomics in ADC and Immuno-Oncology In this episode of the ChatGJP series, Panome Bio CSO Dr. Gary J. Patti joins Chris Eden to explore real-world applications of metabolomics in antibody–drug conjugates (ADCs) and immuno-oncology. The...
by Jason Heaviland | Dec 17, 2025 | Uncategorized
The Critical Challenge of Model Validation in Alzheimer’s Drug Development The pharmaceutical industry faces a persistent challenge in neurodegenerative disease research: ensuring that preclinical models accurately recapitulate the complex biochemical landscape...
